{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T15:59:56Z","timestamp":1770739196747,"version":"3.49.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2008,1,2]],"date-time":"2008-01-02T00:00:00Z","timestamp":1199232000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0001401","type":"journal-article","created":{"date-parts":[[2008,1,3]],"date-time":"2008-01-03T00:50:13Z","timestamp":1199321413000},"page":"e1401","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":137,"title":["Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine"],"prefix":"10.1371","volume":"3","author":[{"given":"Beno\u00eet","family":"Baras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koert J.","family":"Stittelaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J. M. M.","family":"Thoolen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally P.","family":"Mossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank H. M.","family":"Pistoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"van Amerongen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine A.","family":"Wettendorff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Hanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert D. M. E.","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2008,1,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1056\/NEJMp068205","article-title":"H5N1 influenza\u2013continuing evolution and spread.","volume":"355","author":"RG Webster","year":"2006","journal-title":"N Engl J Med"},{"key":"ref2","article-title":"WHO global influenza preparedness plan: the role of WHO and recommendations for national measures before and during pandemics. WHO\/CDS\/CSR\/GIP\/2005.5.","year":"2005"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ni1343","article-title":"Influenza and the challenge for immunology.","volume":"7","author":"PC Doherty","year":"2006","journal-title":"Nature Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0140-6736(07)61269-0","article-title":"Breaking the immunogenicity barrier of bird flu vaccines.","volume":"370","author":"S Sambhara","year":"2007","journal-title":"The Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1473-3099(06)70364-4","article-title":"Development and evaluation of pandemic influenza vaccines.","volume":"6","author":"I Stephenson","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.immuni.2005.12.005","article-title":"Development of effective vaccines against pandemic influenza.","volume":"24","author":"K Subbarao","year":"2006","journal-title":"Immunity"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature04795","article-title":"Strategies for mitigating an influenza pandemic","volume":"442","author":"NM Ferguson","year":"2006","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1073\/pnas.0601266103","article-title":"Mitigation strategies for pandemic influenza in the United States.","volume":"103","author":"TC Germann","year":"2006","journal-title":"Proc Natl Acad Sc USA"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00430-002-0146-x","article-title":"Experience with the clinical development of influenza vaccines for potential pandemics.","volume":"191","author":"JM Wood","year":"2002","journal-title":"Med Microbiol Immuno"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1056\/NEJMoa060930","article-title":"Three Indonesian clusters of H5N1 virus infection in 2005.","volume":"355","author":"IN Kandun","year":"2006","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(06)68656-X","article-title":"Safety and immunogenicity of an inactivated split-virion infl uenza A\/Vietnam\/1194\/2004 (H5N1) vaccine: phase I randomised trial.","volume":"367","author":"JL Bresson","year":"2006","journal-title":"The Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.","volume":"354","author":"JJ Treanor","year":"2006","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","article-title":"Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.","volume":"370","author":"I Leroux-Roels","year":"2007","journal-title":"The Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/505229","article-title":"Ferrets and the challenges of H5N1 vaccine formulation","volume":"194","author":"AW Hampson","year":"2006","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1128\/JVI.79.4.2191-2198.2005","article-title":"Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004.","volume":"79","author":"EA Govorkova","year":"2005","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/505225","article-title":"Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.","volume":"194","author":"EA Govorkova","year":"2006","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3201\/eid1211.060426","article-title":"Review of aerosol transmission of influenza A virus.","volume":"12","author":"R Tellier","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/425915a","article-title":"Virology: SARS virus infection of cats and ferrets.","volume":"425","author":"BE Martina","year":"2003","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01310622","article-title":"An ELISA for detection of antibodies against influenza A nucleoprotein in humans and various animal species","volume":"115","author":"GF de Boer","year":"1990","journal-title":"Arch Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.4049\/jimmunol.176.10.6333","article-title":"T cell responses are better correlates of vaccine protection in the elderly.","volume":"176","author":"J McElhaney","year":"2006","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0264-410X(00)00310-8","article-title":"A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines.","volume":"19","author":"GF Rimmelzwaan","year":"2000","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.vaccine.2004.11.034","article-title":"Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults.","volume":"23","author":"P Vandepapeli\u00e8re","year":"2005","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nm1210","article-title":"Targeting the innate immune response with improved adjuvants.","volume":"11","author":"A Pashine","year":"2005","journal-title":"Nature Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2249.2004.02371.x","article-title":"Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S\/AS02, in semi-immune adults in The Gambia.","volume":"135","author":"M Pinder","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nm1009","article-title":"A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.","volume":"10","author":"WHH Reece","year":"2004","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4615-1823-5_10","article-title":"MF59: design and evaluation of a safe and potent adjuvant for human vaccines.","volume":"6","author":"G Ott","year":"1995","journal-title":"Pharm Biotechnol."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/meth.1999.0832","article-title":"Squalene and squalane emulsion as adjuvants.","volume":"19","author":"AC Allison","year":"1999","journal-title":"Methods"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1371\/journal.pmed.0030360","article-title":"Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.","volume":"3","author":"AL Suguitan Jr","year":"2006","journal-title":"PLoS Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/507709","article-title":"Cross-Protectiveness and Immunogenicity of Influenza A\/Duck\/Singapore\/3\/97(H5) Vaccines against Infection with A\/Vietnam\/1203\/04(H5N1) Virus in Ferrets.","volume":"194","author":"AS Lipatov","year":"2006","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0166-0934(98)00071-8","article-title":"Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro.","volume":"74","author":"GF Rimmelzwaan","year":"1998","journal-title":"J Virol Methods"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0001401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T09:27:55Z","timestamp":1589016475000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0001401"}},"subtitle":[],"editor":[{"given":"Peter","family":"Sommer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,1,2]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,1,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0001401","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,2]]}}}